---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-109891"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2024-12-18T23:59:59+00:00"
generated_at: "2026-05-29T02:02:32.560186+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# InMed enters $10M standby equity facility with Yorkville; shares at 97% of VWAP

## Summary
- Up to $10M common shares may be sold to YA II PN, Ltd (Yorkville) at 97% of lowest daily VWAP over 3-day pricing period.
- Facility runs until Jan 1, 2027 (~36 months); issuance capped at 19.99% of outstanding (unless pricing conditions met).
- Company pays $25k structuring fee plus 2.50% commitment fee ($250k) – 25% cash upfront, 75% deferred quarterly.
- Proceeds for working capital and general corporate purposes; CEO cites flexibility and extended runway.
- Sales at company's discretion; no obligation to sell any shares.

## SEC filing metadata
- accession: 0001213900-24-109891
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2024-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390024109891/0001213900-24-109891-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390024109891/ea0225022-8k_inmed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-109891
- JSON: https://secwatch.observer/filing/0001213900-24-109891.json
- Plain text: https://secwatch.observer/filing/0001213900-24-109891.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.